The European Investment Bank supports iSTAR Medical, a Belgian medtech company developing a novel ophthalmic implant for patients suffering from glaucoma, the leading cause of irreversible blindness in the world. The unique device is expected to set new medical standards in the fight against the disease. Read more in the press release.
